Senators probe J&J; payments
- Share via
Sens. Charles E. Grassley (R-Iowa) and Herb Kohl (D-Wis.) have asked Johnson & Johnson to provide information about its payments to physicians as part of a widening investigation into drug makers’ influence. The New Brunswick, N.J.-based company said the two powerful lawmakers were probing its ties to psychiatrists.
Johnson & Johnson markets Risperdal, which is prescribed for schizophrenia and bipolar disorder.
The senators also requested information about J&J;’s relationship with doctors who use its Cypher drug-coated stent to prop open arteries, according to a regulatory filing.
In October, Grassley and Kohl questioned Columbia University about cardiology professors who received consulting payments from companies that market stents, including Medtronic Inc., Abbott Laboratories and Johnson & Johnson.
More From the Los Angeles Times
Podcasts
Taped Jan 8, 2026, a year after the Eaton Fire, this episode features Ondi Timoner. After losing her home, she began documenting the displacement and financial struggles of her neighbors, joining My Tribe Rise to help Altadena rebuild and recover.
Attorney Frank Carson defended the accused for decades. Framed for murder and later acquitted, a star witness admitted he lied. Stanislaus County paid $22.5M to settle his estate’s lawsuit.
Hear from the winner of the 1968 Caltech vs MIT electric car race. But it’s not all fresh air: smog devastates communities of color, and the Trump administration may pull the plug on California’s ability to clear its own air.
